VERTEX PHARMACEUTICALS INC / MA Insider Trading for May 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VERTEX PHARMACEUTICALS INC / MA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in VERTEX PHARMACEUTICALS INC / MA for May 2019.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 28 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Option Exercise | M | 77.31 | 113,432 | 8,769,428 | 56,030 | |
May 28 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 175.10 | 113,432 | 19,861,943 | 106,287 | 219.7 K to 106.3 K (-51.63 %) |
May 28 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Buy | M | 77.31 | 113,432 | 8,769,428 | 219,719 | 106.3 K to 219.7 K (+106.72 %) |
May 17 2019 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Sell | S | 165.41 | 83 | 13,729 | 35,003 | 35.1 K to 35 K (-0.24 %) |
May 17 2019 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | EVP and CMO | Sell | S | 165.41 | 241 | 39,864 | 13,736 | 14 K to 13.7 K (-1.72 %) |
May 17 2019 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 165.41 | 91 | 15,052 | 31,553 | 31.6 K to 31.6 K (-0.29 %) |
May 08 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Option Exercise | M | 77.31 | 2,300 | 177,813 | 169,462 | |
May 08 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Option Exercise | M | 77.31 | 30,758 | 2,377,901 | 171,762 | |
May 08 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 175.02 | 2,300 | 402,546 | 106,195 | 108.5 K to 106.2 K (-2.12 %) |
May 08 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Buy | M | 77.31 | 2,300 | 177,813 | 108,495 | 106.2 K to 108.5 K (+2.17 %) |
May 08 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 175.01 | 30,758 | 5,382,958 | 106,195 | 137 K to 106.2 K (-22.46 %) |
May 08 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Buy | M | 77.31 | 30,758 | 2,377,901 | 136,953 | 106.2 K to 137 K (+28.96 %) |
May 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Option Exercise | M | 86.52 | 2,329 | 201,505 | 16,310 | |
May 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Sell | S | 173.72 | 622 | 108,054 | 35,003 | 35.6 K to 35 K (-1.75 %) |
May 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Sell | S | 173.00 | 707 | 122,311 | 35,625 | 36.3 K to 35.6 K (-1.95 %) |
May 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Sell | S | 171.71 | 500 | 85,855 | 36,332 | 36.8 K to 36.3 K (-1.36 %) |
May 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Sell | S | 170.33 | 500 | 85,165 | 36,832 | 37.3 K to 36.8 K (-1.34 %) |
May 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Buy | M | 86.52 | 2,329 | 201,505 | 37,332 | 35 K to 37.3 K (+6.65 %) |
May 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Option Exercise | M | 86.52 | 1,553 | 134,366 | 10,873 | |
May 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Option Exercise | M | 91.05 | 2,155 | 196,213 | 6,466 | |
May 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 173.60 | 593 | 102,945 | 33,240 | 33.8 K to 33.2 K (-1.75 %) |
May 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 172.73 | 400 | 69,092 | 33,833 | 34.2 K to 33.8 K (-1.17 %) |
May 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 171.31 | 320 | 54,819 | 34,233 | 34.6 K to 34.2 K (-0.93 %) |
May 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 170.28 | 240 | 40,867 | 34,553 | 34.8 K to 34.6 K (-0.69 %) |
May 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Buy | M | 86.52 | 1,553 | 134,366 | 34,793 | 33.2 K to 34.8 K (+4.67 %) |
May 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 171.70 | 100 | 17,170 | 33,240 | 33.3 K to 33.2 K (-0.30 %) |
May 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 170.72 | 400 | 68,288 | 33,340 | 33.7 K to 33.3 K (-1.19 %) |
May 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 169.31 | 457 | 77,375 | 33,740 | 34.2 K to 33.7 K (-1.34 %) |
May 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 168.56 | 1,198 | 201,935 | 34,197 | 35.4 K to 34.2 K (-3.38 %) |
May 06 2019 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Buy | M | 91.05 | 2,155 | 196,213 | 35,395 | 33.2 K to 35.4 K (+6.48 %) |
May 03 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Option Exercise | M | 77.31 | 300 | 23,193 | 202,520 | |
May 03 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Option Exercise | M | 77.31 | 10,180 | 787,016 | 202,820 | |
May 03 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 175.04 | 300 | 52,512 | 106,195 | 106.5 K to 106.2 K (-0.28 %) |
May 03 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Buy | M | 77.31 | 300 | 23,193 | 106,495 | 106.2 K to 106.5 K (+0.28 %) |
May 03 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 175.08 | 10,180 | 1,782,314 | 106,195 | 116.4 K to 106.2 K (-8.75 %) |
May 03 2019 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Buy | M | 77.31 | 10,180 | 787,016 | 116,375 | 106.2 K to 116.4 K (+9.59 %) |